Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Preventable Vaccines Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Adult Preventable Vaccines
  • 1.3.3 Pediatric Preventable Vaccines
• 1.4 Market Segment by Application
  • 1.4.1 Global Preventable Vaccines Market Share by Application (2019-2025)
  • 1.4.2 Bacterial Diseases
  • 1.4.3 Virus Diseases
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Preventable Vaccines Market Size
  • 2.1.1 Global Preventable Vaccines Revenue 2014-2025
  • 2.1.2 Global Preventable Vaccines Sales 2014-2025
• 2.2 Preventable Vaccines Growth Rate by Regions
  • 2.2.1 Global Preventable Vaccines Sales by Regions 2014-2019
  • 2.2.2 Global Preventable Vaccines Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Preventable Vaccines Sales by Manufacturers
  • 3.1.1 Preventable Vaccines Sales by Manufacturers 2014-2019
  • 3.1.2 Preventable Vaccines Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Preventable Vaccines Revenue by Manufacturers (2014-2019)
  • 3.2.2 Preventable Vaccines Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Preventable Vaccines Market Concentration Ratio (CR5 and HHI)
• 3.3 Preventable Vaccines Price by Manufacturers
• 3.4 Key Manufacturers Preventable Vaccines Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Preventable Vaccines Market
• 3.6 Key Manufacturers Preventable Vaccines Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Adult Preventable Vaccines Sales and Revenue (2014-2019)
  • 4.1.2 Pediatric Preventable Vaccines Sales and Revenue (2014-2019)
• 4.2 Global Preventable Vaccines Sales Market Share by Type
• 4.3 Global Preventable Vaccines Revenue Market Share by Type
• 4.4 Preventable Vaccines Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Preventable Vaccines Sales by Application

6 United States

• 6.1 United States Preventable Vaccines Breakdown Data by Company
• 6.2 United States Preventable Vaccines Breakdown Data by Type
• 6.3 United States Preventable Vaccines Breakdown Data by Application

7 European Union

• 7.1 European Union Preventable Vaccines Breakdown Data by Company
• 7.2 European Union Preventable Vaccines Breakdown Data by Type
• 7.3 European Union Preventable Vaccines Breakdown Data by Application

8 China

• 8.1 China Preventable Vaccines Breakdown Data by Company
• 8.2 China Preventable Vaccines Breakdown Data by Type
• 8.3 China Preventable Vaccines Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Preventable Vaccines Breakdown Data by Company
• 9.2 Rest of World Preventable Vaccines Breakdown Data by Type
• 9.3 Rest of World Preventable Vaccines Breakdown Data by Application
• 9.4 Rest of World Preventable Vaccines Breakdown Data by Countries
  • 9.4.1 Rest of World Preventable Vaccines Sales by Countries
  • 9.4.2 Rest of World Preventable Vaccines Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 GlaxoSmithKline
  • 10.1.1 GlaxoSmithKline Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.1.4 Preventable Vaccines Product Introduction
  • 10.1.5 GlaxoSmithKline Recent Development
• 10.2 Merck
  • 10.2.1 Merck Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.2.4 Preventable Vaccines Product Introduction
  • 10.2.5 Merck Recent Development
• 10.3 Novartis
  • 10.3.1 Novartis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.3.4 Preventable Vaccines Product Introduction
  • 10.3.5 Novartis Recent Development
• 10.4 Pfizer
  • 10.4.1 Pfizer Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.4.4 Preventable Vaccines Product Introduction
  • 10.4.5 Pfizer Recent Development
• 10.5 Sanofi
  • 10.5.1 Sanofi Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.5.4 Preventable Vaccines Product Introduction
  • 10.5.5 Sanofi Recent Development
• 10.6 Takeda Pharmaceutical
  • 10.6.1 Takeda Pharmaceutical Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.6.4 Preventable Vaccines Product Introduction
  • 10.6.5 Takeda Pharmaceutical Recent Development
• 10.7 Abbott
  • 10.7.1 Abbott Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.7.4 Preventable Vaccines Product Introduction
  • 10.7.5 Abbott Recent Development
• 10.8 Roche
  • 10.8.1 Roche Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.8.4 Preventable Vaccines Product Introduction
  • 10.8.5 Roche Recent Development
• 10.9 AstraZeneca
  • 10.9.1 AstraZeneca Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.9.4 Preventable Vaccines Product Introduction
  • 10.9.5 AstraZeneca Recent Development
• 10.10 Mitsubishi Tanabe Pharma
  • 10.10.1 Mitsubishi Tanabe Pharma Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Preventable Vaccines
  • 10.10.4 Preventable Vaccines Product Introduction
  • 10.10.5 Mitsubishi Tanabe Pharma Recent Development
• 10.11 Lupin
• 10.12 Serum Institute of India
• 10.13 LG Life Sciences
• 10.14 S K Chemicals
• 10.15 Shenzhen Kangtai Biological Products
• 10.16 Sinovac Biotech
• 10.17 Janssen Pharmaceuticals
• 10.18 Crucell
• 10.19 Bavarian Nordic
• 10.20 Baxter
• 10.21 Bharat Biotech
• 10.22 Dynavax
• 10.23 Valeant Pharmaceuticals
• 10.24 Protein Sciences
• 10.25 Panacea Biotec

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Preventable Vaccines Sales Channels
  • 11.2.2 Preventable Vaccines Distributors
• 11.3 Preventable Vaccines Customers

12 Market Forecast

• 12.1 Global Preventable Vaccines Sales and Revenue Forecast 2019-2025
• 12.2 Global Preventable Vaccines Sales Forecast by Type
• 12.3 Global Preventable Vaccines Sales Forecast by Application
• 12.4 Preventable Vaccines Forecast by Regions
  • 12.4.1 Global Preventable Vaccines Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Preventable Vaccines Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Preventable Vaccines is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Preventable Vaccines.

This report studies the global market size of Preventable Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Preventable Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Valeant Pharmaceuticals
Protein Sciences
Panacea Biotec

Market Segment by Product Type
Adult Preventable Vaccines
Pediatric Preventable Vaccines

Market Segment by Application
Bacterial Diseases
Virus Diseases

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Preventable Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Preventable Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Preventable Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025